A multidisciplinary group of physicians, computational scientists, and data engineers united by a shared mission: using AI in dermatology and oncology to improve outcomes for patients with melanoma, cutaneous oncology, immune-mediated skin disease, and inflammatory skin conditions from cancer treatment.
Dr. Semenov is a dermatologist and clinician-scientist with expertise in applied mathematics, biostatistics, epidemiology, clinical informatics in melanoma, and health economics. He is Associate Professor of Dermatology at Harvard Medical School, Vice Chair of Medical Informatics for Mass General Brigham (MGB) Dermatology, and co-Director of the Oncodermatology Program. He received his Medical Doctorate, Master’s, and Bachelor’s degrees from Johns Hopkins University and completed his dermatology residency at Washington University in St. Louis in 2019.
Since joining MGB in 2019, he has built a nationally and internationally recognized clinical and translational research program at the interface of cutaneous oncology, AI in skin disease, and dermatology precision medicine. The Oncodermatology Program serves as a national model for specialized oncodermatology care and the management of immune-mediated skin disease and skin toxicities from checkpoint blockade. His group has published 150+ peer-reviewed papers, mentored 50+ trainees, and sustained federal funding from the NIH and Department of Defense. His Google Scholar profile records 5,000+ citations, an h-index of 40, and an i10-index of 80 (as of September 13, 2026).
Dr. Semenov serves as Statistics Editor for the Journal of the American Academy of Dermatology, Associate Editor, Oncodermatology and Cutaneous Oncology for the International Journal of Dermatology, and Associate Editor for npj Digital Medicine. His research spans AI in dermatology, AI in oncology, inflammatory skin disease, and clinical trials in oncodermatology. He speaks English and Russian.
PhD in Data Science and Statistics. Research focus on survival analysis, nonparametric estimation, and clinical ML methods applied to dermatologic disease.
PhD in Computer Science, ETH Zurich. At HMS since Nov 2022. Works on digital pathology and machine learning for dermatologic disease, with expertise in data management systems and ML infrastructure.
Combined medicine-dermatology resident (PGY-5), Harvard Combined Dermatology Residency Training Program. MD, Harvard Medical School. BA, UC Berkeley.
MS. MD candidate, University of Hawaii John A. Burns School of Medicine.
BS, UCLA. MD candidate, Tufts University School of Medicine.
MS in Biomedical Informatics, Harvard Medical School. MD candidate, Johns Hopkins University School of Medicine.
BS, Washington University in St. Louis. MD candidate, Johns Hopkins University School of Medicine.
BA, Rice University. MEd, National University. MD candidate, Harvard Medical School.
BS in Molecular, Cellular, and Developmental Biology. MD candidate, Icahn School of Medicine at Mount Sinai.
MD candidate, University of Missouri-Kansas City School of Medicine.
PhD student in Biological and Biomedical Sciences, Harvard Medical School, co-mentored with the Laboratory of Systems Pharmacology. Research focus on interpretable AI for histopathology.
Graduate student in the Harvard Department of Biomedical Informatics (HMS DBMI).
MD candidate, Harvard-MIT Program in Health Sciences and Technology (HST). BA in Neuroscience, Colorado College.
PhD student in Computer Science, Emory University. Completed master's thesis research in the lab through the Biomedical Informatics program at Harvard Medical School.
Undergraduate student at Dartmouth College. Research focus on computational approaches to dermatology and skin cancer informatics.
PhD student in the Harvard Bioinformatics and Integrative Genomics (BIG) program. MMSc in Biomedical Informatics, Harvard Medical School (Class of 2026). Dunleavy Master's Thesis Research Fund Scholar. BS in Computational and Systems Biology, UCLA.
MD-MBA candidate, Harvard Medical School and Harvard Business School.
BS in Biology, Health & Society, University of Michigan. MD/MPH candidate, Case Western Reserve University School of Medicine.
Medical student, University of Rochester School of Medicine and Dentistry.
Dr. Semenov has mentored 50+ trainees, resulting in 44 mentored first-author publications. Alumni have gone on to leading academic medical centers, PhD programs, and faculty positions worldwide.
| Years | Name | Training Affiliation | Current Position |
|---|---|---|---|
| 2021–2025 | Guihong Wan, PhD | Postdoctoral Fellow, MGB / HMS | Assistant Professor of Biological Sciences, University of Chicago. NIH K99/R00 recipient. |
| Years | Name | Training Affiliation | Current Position |
|---|---|---|---|
| 2015–2016 | Amy Huang, MD, MPH | Medical Student, Johns Hopkins University School of Medicine | Attending Dermatologist, Skin Care Physicians |
| 2017–2018 | Abby Rosenberg, MD, MPHS | MD-MPHS Candidate, Washington University School of Medicine | Attending Dermatologist, Saint Louis Dermatology Center |
| 2018–2019 | Christina Herbosa, MD, MPHS | MD-MPHS Candidate, Washington University | OB/GYN Resident, Washington University School of Medicine |
| 2019–2020 | Gabriel Molina, MD | MD Candidate, Harvard Medical School | Dermatology Resident, Stanford University |
| 2019–2020 | Trisha Bhat, MD, MPHS | MD-MPHS Candidate, Washington University | Attending Dermatologist, VistaMD |
| 2019–2020 | Wesley Hodges, MD, MPHS | MD-MPHS Candidate, Washington University | Dermatology Resident, Washington University in St. Louis |
| 2020 | Chenyue Lu, MBI | MBI Student, Harvard Medical School | PhD Student, Computer Science, MIT |
| 2020–2021 | Mark Kalinich, MD, PhD | MD Candidate, Harvard Medical School | Co-Founder, Watershed Bioinformatics |
| 2020–2021 | Vartan Pahalyants, MD, MBA | MD Candidate, Harvard Medical School | Mohs / Dermatologic Oncology Fellow, MD Anderson Cancer Center |
| 2020–2021 | William Murphy, MD, MBA | MD Candidate, Harvard Medical School | Attending Dermatologist, Memorial Sloan Kettering Cancer Center |
| 2020–2021 | Shannon Wongvibulsin, MD, PhD | MSTP Student, Johns Hopkins University School of Medicine | Dermatologist Investigator Research Fellow, UCLA |
| 2020–2021 | Ojiugo Ugwu-Dike, MD | Dermatology Resident, New York University | Dermatology Resident, New York University |
| 2020–2022 | Neel Raval, MD, MPHS | MD-MPHS Candidate, Washington University | Dermatology Resident, Washington University School of Medicine |
| 2020–2023 | Nikolai Klebanov, MD | Dermatology Resident, MGB | Instructor of Dermatology, Beth Israel Lahey Health |
| 2020–2024 | Nicholas Theodosakis, MD, PhD | 2+2 Dermatology Resident, MGB | Instructor of Dermatology, Massachusetts General Hospital |
| 2021–2022 | Bruce Tiu, MD | MD Candidate, Harvard Medical School | Internal Medicine Resident, Massachusetts General Hospital |
| 2021–2022 | Nga Nguyen, MD-MPH | MD-MPH Candidate, Harvard Medical School | Radiation Oncology Resident, Wake Forest University |
| 2021–2023 | Shijia Zhang, MBI | MBI Student, Harvard Medical School | PhD Student, Biomedical Informatics, Johns Hopkins University |
| 2021–2023 | Kimberly Tang, MD | MD Candidate, Harvard Medical School | Dermatology Resident, Vanderbilt University |
| 2021–2023 | Bonnie Leung, MD | MD Candidate, Harvard Medical School | Dermatology Resident, Baylor College of Medicine |
| 2021–2023 | Jordan Phillips, MD | MD Candidate, Harvard Medical School | Dermatology Resident, Mayo Clinic Jacksonville |
| 2021–2023 | Nora Atanasova, MD | MD Candidate, Harvard Medical School | Dermatology Resident, University of Washington |
| 2021–2023 | Ruple Jairath, MD | MD Candidate, Harvard Medical School | Dermatology Resident, Indiana University |
| 2022–2023 | Wenxin Chen, MBI | MBI Student, Harvard Medical School | PhD Student, Computer Science, Cornell University |
| 2022–2023 | Katie Roster, MD | MD Candidate, Harvard Medical School | Dermatology Resident, Georgetown–MedStar Combined Med-Derm Program |
| 2022–2023 | Hannah Rashdan, MD | MD Candidate, Harvard Medical School | Dermatology Resident, University of Chicago |
| 2022–2024 | Ahmad Rajeh, MD, MS | MD Candidate, Harvard Medical School | Dermatology Resident, Washington University in St. Louis |
| 2022–2024 | Mia DeSimone, MD, MPH | Dermatopathology Fellow, Brigham and Women's Hospital | Instructor of Pathology, Brigham and Women's Hospital |
| 2023–2024 | Boshen Yan, MBI | MBI Student, Harvard Medical School | PhD Student, Computational Biology, Carnegie Mellon University |
| 2023–2024 | Crystal Chang, MD, MS | MD-MS Candidate, Harvard Medical School | Incoming Dermatology Resident, Kaiser Permanente (Los Angeles) |
| 2023–2025 | Sara Khattab, MD | MD Candidate, Harvard Medical School | Incoming Dermatology Resident, Oregon Health & Science University |
| 2024–2026 | Debby Cheng, MD | MD Candidate, Harvard Medical School | Incoming Dermatology Resident, Johns Hopkins University |
| 2024–2026 | Olivia Burke, MD | MD Candidate, University of Miami Miller School of Medicine | Incoming Dermatology Resident, University of Miami |
| 2023–2025 | Emma Beagles, MD | MD Candidate, Harvard Medical School | Incoming Dermatology Resident, Washington University in St. Louis |
| 2024–2025 | Jenny Lai, MD, PhD | MD Candidate, Harvard Medical School | Incoming Dermatology Resident, Yale University (Physician-Scientist Track) |
| 2024–2025 | Ninghui Hao, MBI | MBI Student, Harvard Medical School | PhD Student, Computer Science, University of Texas at Dallas |
| 2024–2026 | Soma Jobbagy, MD, PhD | Dermatopathology Fellow, Dartmouth-Hitchcock Medical Center | Attending Dermatopathologist, Dartmouth-Hitchcock Medical Center |
| 2025–2026 | Caitlyn Duffy | MD Candidate, Albert Einstein College of Medicine | MD Candidate, Albert Einstein College of Medicine |
Dr. Semenov is a board-certified dermatologist and internationally recognized expert in cutaneous oncology and oncodermatology. He provides comprehensive, multidisciplinary care for patients with melanoma and skin cancer across all stages of disease, patients experiencing skin side effects from immunotherapy and other cancer treatments, and patients with complex immune-mediated skin disorders. He has contributed to the development of clinical guidelines for the diagnosis and management of immunotherapy-related skin toxicities and receives referrals from across the United States. Since its launch in 2022, the MGB Oncodermatology Program has grown to 600+ referrals annually and serves as a national model — adopted by institutions across the US and internationally.
His clinical practice focuses on: